Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-10
2006-10-10
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S215000, C548S233000, C514S374000
Reexamination Certificate
active
07119113
ABSTRACT:
The invention relates to carboxamide derivatives as defined in the specification and claims, to a process for their preparation, to pharmaceutical compositions comprising them and to their use as mGluR1 enhancers in the treatment and prevention of neurological disorders and diseases, such as Alzheimer's disease and dementia.
REFERENCES:
patent: 6462198 (2002-10-01), Bleicher et al.
patent: 6596743 (2003-07-01), Bleicher et al.
patent: 6803381 (2004-10-01), Bleicher et al.
patent: WO 00/63166 (2000-10-01), None
Knoflach et al., Proc. Nat. Acad. Sci. USA vol. 98: 13402-13407 (2001).
Schlaeger et al., New Dev. New Appl. Anim. Cell Techn. Proc. ESACI Meet. vol. 15 (1998) pp. 105-112 & 117-120.
Houston Biochem. Pharmacol. vol. 47 No. 9, pp. 1469-1479 (1994).
Crank & Foulis, J. Med. Chem. vol. 14: pp. 1075-1077 (1971).
Saha et al. J. Am. Chem. Soc. 111 p. 4856-4859 (1989).
Huwyler Joerg
Knoflach Frederic
Vieira Eric
Wichmann Juergen
Hoffmann-La Roche Inc.
Johnson George W.
Prior Kimberly J.
Rocha-Tramaloni Patricia S.
Shameem Golam M. M.
LandOfFree
Oxazoles as mGluR1 enhancers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxazoles as mGluR1 enhancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazoles as mGluR1 enhancers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3699339